"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug,"
A 10-year Finnish study found insulin resistance biomarkers were associated with increased aortic stenosis risk, with hazard ratios ranging from 1.38 to 1.47, independent of age, BMI, and hypertension.